00000nam 2200000zi 4500 9.914234 CaOODSP 20230217083031 m o d f cr mn||||||||| 220808t20232023onc ob f000 0 eng d 9780660449388 CaOODSP eng rda CaOODSP n-cn--- HP40-321/2022E-PDF NACI literature review on the effects of palivizumab prophylaxis on reducing the complications associated with respiratory syncytial virus in infants. Effects of palivizumab prophylaxis on reducing complications associated with respiratory syncytial virus in infants Ottawa, Ontario : Public Health Agency of Canada = Agence de la santé publique du Canada, 2023. ©2023 1 online resource (133 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. "Publication date: February 2023." At head of title: An Advisory Committee Review National Advisory Committee on Immunization (NACI). Issued also in French under title: Revue de la littérature du CCNI sur les effets de la prophylaxie par palivizumab sur la réduction des complications associées au virus respiratoire syncytial chez les nourrissons. Includes bibliographical references (pages 46-50). "The literature review examined the evidence on the effectiveness of palivizumab (PVZ) prophylaxis compared to the administration of placebo or to no prophylaxis in reducing the complications associated with RSV infection in children. The outcomes of interest included hospitalization, length of hospital stay, stay in intensive care, length of stay (LOS) in intensive care, use of oxygen therapy, length of oxygen therapy use, use of mechanical ventilation (MV), length of MV use, long-term sequelae (e.g., wheezing, asthma), and mortality"--Executive summary, page 6. Palivizumab Canada. Respiratory syncytial virus Canada. Infants Diseases Canada. Public Health Agency of Canada, issuing body. Revue de la littérature du CCNI sur les effets de la prophylaxie par palivizumab sur la réduction des complications associées au virus respiratoire syncytial chez les nourrissons. (CaOODSP)9.914235 PDF 1.54 MB https://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-321-2022-eng.pdf 220363